Cookie Consent by FreePrivacyPolicy.com
genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555 858 -31 / 32 / 33 · Fax: +49 203 / 35 82 99
menuicon
slider
Mission 2024:

Genekam making ready
for Nasdaq IPO 2024

Latest News:

Genekam to attend BIO CEO & Investor Conference
February 26-27, 2024 | New York

  • EUDAMED

    A number of Genekam products are registered with EUDAMED
    A step towards meeting the lastest IVDR requirements

  • LSX World conference

    Genekam is to attend LSX World conference 29-30 April, 2024, Business Design Center, London, UK

  • MEDICA 2024

    Visit us on Medica Duesseldorf, 11.-14. November 2024

Our Team

Usually we are composed of 3 or 4 members coming from different scientific fields to create innovative solutions in the field of medicine. Here are experiences of some of our team members:

Member 1: Experience in virology, immunology and stem cells along with the field of management and marketing. Long experience in creating immunotherapies.
Member 2: Experience in Stemcells including cancer stem cells, fluorescent techniques like flow cytometry and molecular biology

TOP